Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03183037 · ClinicalTrials.gov registry record · NA
Acupuncture for Symptoms of Nerve Damage
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT03183037: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03183037 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03183037, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of real acupuncture with placebo acupuncture or usual care on symptoms of nerve damage from chemotherapy.
Interventions
- PROCEDURE Acupuncture
- OTHER Usual Care Group
- PROCEDURE Sham Acupuncture
- BEHAVIORAL questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2017-06-07 |
| Est. Completion | 2024-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03183037
The ClinicalTrials.gov registry entry for NCT03183037 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Acupuncture is the first listed.
NCT03183037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03183037 about?
NCT03183037 is a clinical study titled "Acupuncture for Symptoms of Nerve Damage". The purpose of this study is to compare the effects of real acupuncture with placebo acupuncture or usual care on symptoms of nerve damage from chemotherapy.
What is the current status of trial NCT03183037?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2017-06-07. Estimated completion is 2024-05-02.
What interventions are being tested in trial NCT03183037?
The interventions under investigation include: Acupuncture (PROCEDURE), Usual Care Group (OTHER), Sham Acupuncture (PROCEDURE), questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT03183037?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.